Risks Posed by Reston, the Forgotten Ebolavirus

ABSTRACT Out of the five members of the Ebolavirus family, four cause life-threatening disease, whereas the fifth, Reston virus (RESTV), is nonpathogenic in humans. The reasons for this discrepancy remain unclear. In this review, we analyze the currently available information to provide a state-of-t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Diego Cantoni, Arran Hamlet, Martin Michaelis, Mark N. Wass, Jeremy S. Rossman
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://doaj.org/article/b5a56c02dfd946c096db82e2c53fdd30
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b5a56c02dfd946c096db82e2c53fdd30
record_format dspace
spelling oai:doaj.org-article:b5a56c02dfd946c096db82e2c53fdd302021-11-15T15:22:04ZRisks Posed by Reston, the Forgotten Ebolavirus10.1128/mSphere.00322-162379-5042https://doaj.org/article/b5a56c02dfd946c096db82e2c53fdd302016-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00322-16https://doaj.org/toc/2379-5042ABSTRACT Out of the five members of the Ebolavirus family, four cause life-threatening disease, whereas the fifth, Reston virus (RESTV), is nonpathogenic in humans. The reasons for this discrepancy remain unclear. In this review, we analyze the currently available information to provide a state-of-the-art summary of the factors that determine the human pathogenicity of Ebolaviruses. RESTV causes sporadic infections in cynomolgus monkeys and is found in domestic pigs throughout the Philippines and China. Phylogenetic analyses revealed that RESTV is most closely related to the Sudan virus, which causes a high mortality rate in humans. Amino acid sequence differences between RESTV and the other Ebolaviruses are found in all nine Ebolavirus proteins, though no one residue appears sufficient to confer pathogenicity. Changes in the glycoprotein contribute to differences in Ebolavirus pathogenicity but are not sufficient to confer pathogenicity on their own. Similarly, differences in VP24 and VP35 affect viral immune evasion and are associated with changes in human pathogenicity. A recent in silico analysis systematically determined the functional consequences of sequence variations between RESTV and human-pathogenic Ebolaviruses. Multiple positions in VP24 were differently conserved between RESTV and the other Ebolaviruses and may alter human pathogenicity. In conclusion, the factors that determine the pathogenicity of Ebolaviruses in humans remain insufficiently understood. An improved understanding of these pathogenicity-determining factors is of crucial importance for disease prevention and for the early detection of emergent and potentially human-pathogenic RESTVs.Diego CantoniArran HamletMartin MichaelisMark N. WassJeremy S. RossmanAmerican Society for MicrobiologyarticleEbolaviruspathogenicityRestonMicrobiologyQR1-502ENmSphere, Vol 1, Iss 6 (2016)
institution DOAJ
collection DOAJ
language EN
topic Ebolavirus
pathogenicity
Reston
Microbiology
QR1-502
spellingShingle Ebolavirus
pathogenicity
Reston
Microbiology
QR1-502
Diego Cantoni
Arran Hamlet
Martin Michaelis
Mark N. Wass
Jeremy S. Rossman
Risks Posed by Reston, the Forgotten Ebolavirus
description ABSTRACT Out of the five members of the Ebolavirus family, four cause life-threatening disease, whereas the fifth, Reston virus (RESTV), is nonpathogenic in humans. The reasons for this discrepancy remain unclear. In this review, we analyze the currently available information to provide a state-of-the-art summary of the factors that determine the human pathogenicity of Ebolaviruses. RESTV causes sporadic infections in cynomolgus monkeys and is found in domestic pigs throughout the Philippines and China. Phylogenetic analyses revealed that RESTV is most closely related to the Sudan virus, which causes a high mortality rate in humans. Amino acid sequence differences between RESTV and the other Ebolaviruses are found in all nine Ebolavirus proteins, though no one residue appears sufficient to confer pathogenicity. Changes in the glycoprotein contribute to differences in Ebolavirus pathogenicity but are not sufficient to confer pathogenicity on their own. Similarly, differences in VP24 and VP35 affect viral immune evasion and are associated with changes in human pathogenicity. A recent in silico analysis systematically determined the functional consequences of sequence variations between RESTV and human-pathogenic Ebolaviruses. Multiple positions in VP24 were differently conserved between RESTV and the other Ebolaviruses and may alter human pathogenicity. In conclusion, the factors that determine the pathogenicity of Ebolaviruses in humans remain insufficiently understood. An improved understanding of these pathogenicity-determining factors is of crucial importance for disease prevention and for the early detection of emergent and potentially human-pathogenic RESTVs.
format article
author Diego Cantoni
Arran Hamlet
Martin Michaelis
Mark N. Wass
Jeremy S. Rossman
author_facet Diego Cantoni
Arran Hamlet
Martin Michaelis
Mark N. Wass
Jeremy S. Rossman
author_sort Diego Cantoni
title Risks Posed by Reston, the Forgotten Ebolavirus
title_short Risks Posed by Reston, the Forgotten Ebolavirus
title_full Risks Posed by Reston, the Forgotten Ebolavirus
title_fullStr Risks Posed by Reston, the Forgotten Ebolavirus
title_full_unstemmed Risks Posed by Reston, the Forgotten Ebolavirus
title_sort risks posed by reston, the forgotten ebolavirus
publisher American Society for Microbiology
publishDate 2016
url https://doaj.org/article/b5a56c02dfd946c096db82e2c53fdd30
work_keys_str_mv AT diegocantoni risksposedbyrestontheforgottenebolavirus
AT arranhamlet risksposedbyrestontheforgottenebolavirus
AT martinmichaelis risksposedbyrestontheforgottenebolavirus
AT marknwass risksposedbyrestontheforgottenebolavirus
AT jeremysrossman risksposedbyrestontheforgottenebolavirus
_version_ 1718428093002022912